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Background: The construction and electrochemical response characteristics of Poly (vinyl chloride) membrane
sensors for moxifloxacin HCl (MOX) are described. The sensing membranes incorporate ion association complexes
of moxifloxacin cation and sodium tetraphenyl borate (NaTPB) (sensor 1), phosphomolybdic acid (PMA) (sensor 2)
or phosphotungstic acid (PTA) (sensor 3) as electroactive materials.
Results: The sensors display a fast, stable and near-Nernstian response over a relative wide moxifloxacin concentration
range (1 × 10−2 - 4.0 × 10−6, 1 × 10−2 - 5.0 × 10−6, 1 × 10−2 - 5.0 × 10−6 M), with detection limits of 3 × 10−6, 4 × 10−6 and
4.0 × 10−6 M for sensor 1, 2 and 3, respectively over a pH range of 6.0 - 9.0. The sensors show good discrimination of
moxifloxacin from several inorganic and organic compounds. The direct determination of 400 μg/ml of moxifloxacin
show an average recovery of 98.5, 99.1 and 98.6% and a mean relative standard deviation of 1.8, 1.6 and 1.8% for
sensors 1, 2 and 3 respectively.
Conclusions: The proposed sensors have been applied for direct determination of moxifloxacin in some
pharmaceutical preparations. The results obtained by determination of moxifloxacin in tablets using the proposed
sensors are comparable favorably with those obtained using the US Pharmacopeia method. The sensors have
been used as indicator electrodes for potentiometric titration of moxifloxacin.
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PotentiometryBackground
Moxifloxacin (MOX) (1-cyclopropyl-6-fluoro-1,4- dihydro-
8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo [3,4-b]pyri-
din-6-yl]4-oxo-3 quinoline carboxylic acid) (Figure 1) is
an advanced-generation, 8-methoxyquinolone derivate of
fluoroquinolone antibacterial agent that is synthetic. It was
discovered in 1999 [1,2]. Moxifloxacin is a broad-spectrum
antibiotic that is active against both Gram-positive and
Gram-negative bacteria. It functions by inhibiting DNA
gyrase, a type II topoisomerases, and topoisomerase IV
[3], enzymes necessary to separate bacterial DNA, thereby
inhibiting cell replication.* Correspondence: gamal_most@yahoo.com
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article, unless otherwise stated.Various methods cited in literature for its determina-
tions involve, spectrophotometry [4,5], spectrofluorimetry
[6], atomic absorption spectrometry [7], conductometry [7],
voltammetry [8], high performance liquid chromatography-
ultraviolet (HPLC-UV) [9-11], HPLC-fluorescence (HPLC-
Fl) [12-14] capillary electrophoresis (CE) [15,16], and
HPLC-mass spectrometry (HPLC-MS) [17,18]. However,
most of these methods involve time-consuming proce-
dures, derivatization and/ or sophisticated instruments.
Due to the fact that MOX is a compound of great phar-
macological and analytical importance, in recent years,
there has been an increased interest to develop accurate
analytical methods which are valid for quantification of
MOX in biological and pharmaceutical samples.
Potentiometric methods, using ion selective electrodes,
have found wide application [19-21] being simple, eco-ntral Ltd. This is an Open Access article distributed under the terms of the
//creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Chemical structure of moxifloxacin hydrochloride.
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with applicability to turbid and colored solutions, and
offering enough selectivity towards the drug in the pres-
ence of various pharmaceutical excipients. To the best
of our knowledge till now no potentiometric membrane
sensors for MOX have been published. The proposed
sensors are based on the use of PVC membrane sensor of
MOX - tetraphenylborate or MOX-phosphomolybdate or
MOX-phosphotungstate as electroactive materials. The
present work describes the construction and evaluation of
novel PVC electrochemical sensors for the sensitive and




All potentiometric measurements were made at 25 ± 1°C
unless otherwise stated using an Orion pH/mV meter
(model 330) using MOX membrane sensors in conjunc-
tion with an Orion double junction Ag/AgCl reference
electrode (model 90–02) containing 10% (w/v) potassium
nitrate in the outer compartment. Adjustment of pH was
made with a combined Ross glass pH electrode (Orion
81–02) for all pH measurements.
Reagents and materials
All chemicals used were of analytical reagent grade unless
otherwise stated and doubly distilled water was used
throughout. Polyvinyl chloride powder (PVC) high molecu-
lar weight, dibutyl sebacate (DBS), dioctyl phthalate (DOP),
o-nitrophenyl octylether (NPOE), tetrahydrofurane (THF)
of purity > 99% were obtained from Aldrich Chemical
Company and MOX was obtained from Sigma Chemical
Company, Germany. Sodium tetraphenylborate (NaTPB),
phosphomolybdic acid (PMA) and phosphotungstic acid
(PTA), were obtained from BDH, Chemical Ltd. Avelox
400 mg, Manufactured by Bayer was obtained from local
pharmacy. The stock solution of 1 × 10−2 M MOX was
prepared by dissolving the appropriate amount of MOX
in 100 ml of water. Five standard MOX solutions were
prepared in the range of 1 × 10−2 - 1 × 10−6 M by dilutingthe appreciate amount in double distilled water. Tris
buffer of pH 7.0 was prepared by mixing 100 ml of 0.1 M
tris(hydroxymethyl) aminomethane hydrochloride, with
appropriate 0.1 M HCl.
Preparation of the MOX-PVC membrane sensors
Upon the addition of 25 ml of 1 × 10−2 M of MOX solution
to 25 ml each of 1 × 10−2 M sodium tetraphenyl borate
or 75 ml of 1 × 10−2 M of MOX solution to 25 ml phos-
photungstic acid respectively, a whitish precipitate of
MOX-TPB or yellowish precipitate of MOX-PA or MOX-
PT were formed, respectively. The precipitate was filtered
off through a Whatman filter paper No. 42, washed with
cold deionized water until no chloride ion was detected
into the washing solution. The precipitate was dried under
vacuum for 48 h, then grinded to a fine powder in mortar,
forming ion-pairs complex. The elemental analysis con-
firmed the formation of 1:1 or 3:1 complex of MOX:TPB
or MOX:PM or MOX:PT, respectively. Portion of ten mg
of the prepared ion associate complexes were thoroughly
mixed with 190 mg PVC powder, 350 mg of DBS or DOP
or NPOE and 5 ml THF in glass Petri dishes (5 cm
diameter). After the constituents being well mixed, the
solvent has been allowed to evaporate overnight while the
sensing membranes have been formed. The PVC master
membranes were sectioned with a cork borer (10 mm
diameter) and glued to a polyethylene tube (3 cm length,
8 mm I.D.) using THF [22,23]. Laboratory made electrode
bodies were used, which consisted of a glass tube, to
which the polyethylene tube is attached at one end and
filled with internal reference solution (equal volumes of
1 × 10−2 M aqueous solution of MOX and KCl). Ag/AgCl
internal reference electrode (1.0 mm diameters) was used.
The indicator electrode was conditioned by soaking in a
1 × 10−2 M aqueous MOX solution for 1 h and stored in
the same solution when not in use.
Procedure
The moxifloxacin PVC membrane sensors were calibrated
by immersion in conjunction with the reference electrode
in a 50 ml beaker containing 9.0 ml of tris-buffer of
pH 7.0. Then 1.0 ml aliquot of MOX solution was added
with continuous stirring, to give final MOX concentration
ranging from 1 × 10−2 to 1 × 10−6 M and the potential was
recorded after stabilization to ± 0.5 mV. A calibration
curves were constructed by plotting the recorded poten-
tials as a function of -log [MOX]. The resulting graphs
were used for subsequent determination of unknown
moxifloxacin concentration.
Determination of moxifloxacin in the pharmaceutical
dosage forms
Ten tablets of Avelox 400 mg were accurately weighed,
crushed, mixed in a mortar. An appropriate amount
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transferred to a 100 ml beaker and dissolved in double
distilled water, sonication for about 15 min and completed
to the mark with the water. A 5.0 ml aliquots of these
solutions were transferred to 50 ml standard flask, the pH
was adjusted to 7.0 using tris buffer and completed to the
mark with water. The potential of the solution was mea-
sured using MOX-sensors in conjunction with an Orion
Ag/AgCl double junction reference electrode. The potential
of the stirred solution was recorded after the signal stab-
ilization (±0.5 mV/min) and the concentration was calcu-
lated from the previous calibration graph under identical
experimental conditions from standard solutions of MOX.
Alternatively, the potentials displayed by moxifloxacin
test solution before and after the addition of a 1.0 ml
aliquot of 1 × 10−3 M moxifloxacin were measured. The
change in the potential readings was recorded and used to
calculate the unknown moxifloxacin concentration in the
test solution using the standard addition technique [24].
Reconstituted powder: one mixture was prepared with a
known amount of moxifloxacin powdered (20 mg) and
other components such as starch, lactose and magnesium
stearate. The accuracy of the potentiometric determination
of MOX in this powdered was checked by evaluation the
recovery.
Results and discussion
Sodium tetraphenyl borate, phosphomolybdic acid, and
phosphotungstic acid were tested as ion-pairing agent for
the preparation of electroactive ion association complexes
for MOX. Sparingly soluble complexes of MOX-TPB,
MOX- PM or MOX - PT have been instantaneously
formed upon the addition of MOX solution to solutions
of Na TPB, PMA or PTA respectively. The dry powder of
the formed ion pairs are used for the construction of a
new moxifloxacin ion selective electrodes. The elemental
analysis showed that the composition of the complex is
1:1 in case of MOX:TPB, 3:1 for MOX: PM or MOX-PT
respectively. Plasticized polymeric membranes were pre-
pared by using membrane cocktails with compositions
1.82% of the corresponding ionic pair (MOX-TPB or
MOX-PM or MOX-PTA), 34.54% of PVC and 63.64% of
the corresponding plasticizer (DBS, DOP and NPOE).
Effect of plasticizer type on the characteristic
performance of the sensors
Moxifloxacin ion-selective membrane sensors with different
electroactive materials were investigated in order to com-
pare their performance. Three reagents were investigated as
possible counter ion for the preparation of the electroactive
complex of MOX, namely TPB or PM or PTA were tested
as ion-pair reagents. The obtained ion-pairs combined
with three plasticizer, DOP, DBS and NPOE to give dif-
ferent combinations were tested. It is well known thatthe construction of PVC based ISEs required the use of
a plasticizer which acts as a fluidizer allowing
homogenous dissolution and diffusion mobility of the
ion-pair inside the membrane. PVC membrane sensor
of MOX-TPB, MOX-PM or MOX-PT with different
plasticizer namely (DBS or DOP or NPOE) was found
to be all suitable and optimum available mediators for
MOX membrane sensors. In fact, o-NPOE was found
to be the optimum available mediator for MOX-TPB,
MOX-PM or MOX-PT membrane sensors (ion-associates).
The use of non polar mediators such as DBS, DOP gave
less solubility of the ion-pair and less response of the
analyte compared with o-NPOE.(slope about 50.0 mV per
concentration decade for both DBS and DOP respectively).
It seems that o-NPOE improves the membrane selectiv-
ity due to its high dialectical constant (ε = 24), affects
considerable dissolution of ion-association within the
membrane; consequently enhances its partition coefficient
in the membrane and also provided suitable mechanical
property of the membrane compared with less permittivity
plasticizers of DBS (ε = 4) or DOP (ε = 7) and the solubility
of electroactive materials are relatively small compared
with NPOE. Ortho-nitrophenyl octylether was used in
case of MOX-TPB, MOX-PM or MOX-PT for carrying
out other experiments in this investigation.
Effect of pH and the response time
The electrode response for different moxifloxacin concen-
trations was tested at different pH values, the pH being
adjusted using hydrochloric acid or sodium hydroxide.
The MOX-PVC electrode dipped into MOX solution of
1 × 10−3 and 1 × 10−4 M the potential of the electrode was
plotted against the pH of solution. The potentials show
that the slope per concentration decade is constant
(~53.0 ± 0.5 or 54.5 ± 0.5 or 55.0 ± 0.5 mV for MOX -PM
or MOX -PT respectively) in the pH range of 6–9.0
(Figure 2). At higher pH values (>9.5), the potential de-
creased due to the gradual increase in the concentration
of the unprotonated MOX.
Average response time is defined [25] as the time
required for the electrode to reach a stable potential
within ±1 mV of the final equilibrium value. After succes-
sive immersion of the electrode in different moxifloxacin
solutions each having a 10-fold difference in concentration
or after rapid 10-fold increase in concentration by
addition of MOX. The response time was found to be
20s for concentration of ≥1 × 10−3 M and ≤ 30 s for
concentration 1 × 10−4 M. Day-to-day reproducibility of
the sensor is about ± 0.5 mV for the same solution and
the useful lifetime of the sensor is 4 weeks, during
which the potential slope is reproducible to within ±1 mV/
decade. Also after more than one month a new section















































Figure 2 Effect of pH on the response of moxifloxacin sensors A) MOX-TPB, B) MOX-PM and C) MOX-PT using two series of moxifloxacin
solutions: 1 × 10−3M, and 1 × 10−4M.
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The influences of different organic and inorganic ions
on the response of MOX sensors were investigated. The
selectivity coefficients KPotMF ;B were evaluated according
to IUPAC guidelines using the separate solution method
(SSM) or mixed solution method [25,26] in tris-buffersolution of pH 7.0. The selectivity coefficient KpotMOX;B
measured by separate solution method was calculated
from the following equation:
logKpotA;B ¼ EB−EA=S þ 1− ZA=ZB½ log aA ð1Þ
Table 2 Response characteristics of moxifloxacin-PVC
matrix membrane sensors
Parameter MOX-TPB MOX-PM MOX-PT
Slope, (mV/ decade) 53.0 ± 0.5 54.5 ± 0.5 55.0 ± 0.5
Intercept, mV 137.8 ± 0.5 143.03 ± 0.5 141.78 ± 0.5
Correlation coefficient, (r) 0.996 0.995 0.995
Lower limit of detection
(LOD), M
4.0 × 10−6 5 × 10−6 5 × 10−6
Lower limit of quantification
(LOQ), M
3.0 × 10−6 4.0× 10−6 4.0 × 10−6
Response time for
1 × 10−3 M solution, s
30 ± 0.5 30 ± 0.5 30 ± 0.5
Working pH range 6.0 - 9.0 6.0 - 9.0 6.0 - 9.0
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after 1 min of exposing the sensor to the same concen-
tration of MOX and interfering species (1 × 10−3 each)
alternatively. The symbol aA , and aB are the activity of
MOX and interfering species and ZA and ZB are the
charge of moxifloxacin and interfering species and S is
slope of calibration graph (mV/ concentration). The se-
lectivity coefficient by mixed solution method was de-
fined as the activity ratio of primary and interfering ions
that give the same potential change under identical con-
ditions as given in equation 3.
KpotA;B ¼ a`A− aAð Þ=aB ð2Þ
Where a`A known activity of primary ion solution added
into a reference solution that contains a fixed activity (aA)
of primary ions, and the corresponding potential change
(ΔE) is recorded. Next, a solution of an interfering ion (aB)
is added to the reference solution until the same potential
change (ΔE) is recorded. The change in potential pro-
duced at the constant back ground of the primary ion
must be the same in both cases. The results are given in
Table 1. The results reveal reasonable selectivity for MOX
in presence of many related substances.
Sensors characteristics
The potentiometric response characteristics of the moxi-
floxacin sensors based on the use of MOX-TPB, MOX-
PM or MOX-PT ion pair complexes and DBS or DOP or
NPOE as a plasticizer in a PVC matrixes were evaluated
according to IUPAC recommendations [25]. Results in
Table 2 show the characteristics performance of the PVC
membrane sensors. The least squares equations obtained
from the calibration data as follows:Table 1 Potentiometric selectivity coefficients of some
interfering ions, using MOX






Na+a 1.3 × 10−3 1.3 × 10−3 1.65 × 10−3
K+a 2.9 × 10−3 3.33 × 10−3 1.2 × 10−4
Ca2+a 1.5 × 10−3 1.49 × 10−3 1.79 × 10−3
Cu2+a 1.84 × 10−3 1.845 × 10−3 2.4 × 10−2
Co2+ a 9. 5 × 10−3 9. 5 × 10−3 0.0113
Mg2+ a 9.1 × 10−3 1.55 × 10−3 1.65 × 10−2
Magnesium stearateb 2.0 × 10−3 2.18× 10−3 2.4 × 10−3
Glucoseb 2.0 × 10−3 2.09× 10−3 2.4 × 10−3
Lactose monohydrateb 2.0 × 10−3 2.27× 10−3 2.51 × 10−3
Starchb 2.0 × 10−3 2.27× 10−3 1.79 × 10−3
Microcrystalline celluloseb 2.0 × 10−3 2.27× 10−3 1.79 × 10−3
aseparate solution method and bmixed solution method.E mVð Þ ¼ Slog MOX½  þ Intercept ð3Þ
where E, is the potential of the electrode, S equal slope
of the electrodes (53.0 ± 0.5, 54.5 ± 0.5 and 55.5 ± 0.5 mV
for MOX-TPB, MOX-PM, and MOX-PT, respectively)
and intercept (137.8 ± 0.5, 143.04 ± 0.5 and 141.78 ± 0.5
for MOX-TPB, MOX -PM, and MOX -PT, respectively).
Validity of the proposed method
Limit of quantification and limit of detection
Each of different concentration of standard solution
was tested five times. The potentials obtained for the
five analyses were averaged at each concentration. The
average potential was plotted versus concentration. The
relation between potential and concentration is logarithmic
(equation 1) X = S log [MOX] + Y, where X is equal the
potential, S is the slope, and Y is the intercept and ( r ) is
the correlation coefficient. The sensors display a linear
response over the concentration range 1 × 10−2 to 4 × 10−6,
1 × 10−2 to 5.0 × 10−6, 1 × 10−2 to 5.0 × 10−6 M), respectively
over a pH range of 6.0 - 9.0. The limits of detection




















Figure 3 Calibration curve of MOX membrane sensors.
Table 3 Day to day reproducibility of the proposed membrane sensors
Parameter Moxifloxacin (400 μg/ml)* within- day Moxifloxacin (400 μg/ml)* within-days
MOX-TPB MOX-PM MOX-PT MOX-TPB MOX-PM MOX-PT
R,% 98.5 99.1 98.60 98.3 99.0 98.5
R.S.D,% 1.76 1.65 1.78 1.9 1.7 1.9
E,% 1.52 0.9 1.41 1.72 1.0 1.52
Slope 53.0 ± 0.5 54.5 ± 0.5 55.0 ± 0.5 53.0 ± 0.6 54.5 ± 0.6 55.0 ± 0.6
Correlation coefficient 0.998 0.998 0.997 0.997 0.997 0.997
*Average of 5 measurements ± RSD.
*R%, recovery percentage; RSD relative standard deviation.
*E, is error% ( actual concentration –found concentration/actual concentration%).
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limit of detection (LOD) defined as the concentration of
MOX corresponding to the intersection of the extrapolated
linear segment of the calibration graph which is of 3 × 10−6,
4 × 10−6 and 4.0 × 10−6 M for sensor 1, 2 and 3 respectively
( Figure 3).
Recovery
The recoveries of MOX were calculated by comparing
the potential of the measured or found concentration to
direct added standard in tris buffer pH 7.0. The assay of
recovery, at each concentration, was computed using the
following equation:
Recovery %ð Þ ¼ found concentration=added concentrationð Þ
 100:
The average recovery of the direct determinations of
400 μg/ml of MOX was 98.5 , 99.1 and 98.6% with
RSD value of 1.76, 1.65 and 1.78% for sensor 1 , 2 and
3 respectively (Table 3).
Precision and accuracy of the method
The intra-day, inter-day accuracy and precision of the
assays were investigated [27] by the analysis of MOX at
400 μg/ml in five replicate over a period of three days.
The five replicate were subject to estimate the intra-day




SD RSD R E SD R
2.0 0.0297 1.9 97.5 1.9 0.0197 1
4.00 0.0297 1.9 98.1 1.8 0.0197 1
40.0 0.1834 1.9 98.3 1.7 0.1761 1
400.0 2.9664 1.7 98.2 1.2 5.000 1
1000.0 14.1002 1.7 98.3 1.3 16.614 1
4000.0 29.234 1.5 98.3 1.4 27.229 1
SD: standard deviation, RSD: relative standard deviation%, R: recovery%, E: error%.
*Average of 5 measurements.and analyzed daily and linear models were used to deter-
mine concentrations in the quality control samples. Percent
accuracy was determined (using the data from the precision
assessment) as the closeness of found concentration to the
added standards. Precision was reported as% RSD. The re-
sults obtained (Table 3) are within the acceptance range of
less than 3.0% (precision) and more than 98.3% for the
accuracy.Ruggedness
The ruggedness of the potentiometric method was evalu-
ated [27] by carrying out the analysis using two different
analyst (operator) and different instruments on different
days. The RSD of less than 3.0% were observed for repeti-
tive measurements in three different day time periods
using two different instruments and operators. The results
indicate that the method is capable of producing results
with high precision.Robustness
The robustness of the method is demonstrated [27] by
the versatility of the experimental factors that affecting
the potential response (e.g. pH and response time).
Preliminary inspection of the results under these various
conditions suggested that the method is fairly robust, but
the pH of the measuring solution should be in the range
of 6.0-9.0. The optimum pH 7.0 was used using tris buffer.brane sensors
MOX-PT,*
SD R E SD RSD R E
.9 98.0 1.8 0.0220 1.9 98.0 1.95
.8 98.1 1.8 0.0220 1.9 98.1 1.95
.7 99.1 1.74 0.229 1.8 98.4 1.64
.6 98.2 1.74 1.378 1.8 98.6 1.24
.5 98.0 1.54 7.247 1.8 98.5 1.30
.4 98.1 2.05 17.117 1.5 99.5 1.40
Table 5 Determination of moxifloxacin in some pharmaceutical preparations using the proposed membrane sensors
Preparation Moxifloxacin
(nominal,value)
Proposed method* R,% (RSD,%) USP R,%
(RSD,%)MOX-PM MOX-PT MOX-PT
Reconstituted powder 20 mg 98.0(1.6) 98.0 (1.5) 98.5(1.6) 98.5 (1.6)
Avelox tablet 400 mg 98.0 (1.7) 98.0(1.6) 98.5(1.7) 99.0 ( 1.8)
*Average of five determinations.
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The applicability of the MOX membrane sensors for
determination of the drug in the dosage forms was firstly
checked by the studying the recovery of an accurate
amount of pure MOX in solutions.
The analysis of 2.0 – 4000.0 μg/ml MOX solutions (in
five replicate) by direct potentiometry gave an average
recovery of 98.1, 98.25 and 98.51% with a relative standard
deviation of 1.76, 1.65 and 1.78% for sensor 1, 2 and 3
respectively, results are shown in Table 4.
The applicability of the MOX-membrane sensors to
the determination of the drug in the dosage forms was
firstly checked by studying the recovery of an accurate
amount of pure MOX in a reconstituted powder samples.
The recovery obtained from five measurements was
found to be 98.0 or 98.0 or 98.5% with a relative stand-
ard deviation of 1.7 or 1.6 or 1.7% for MOX- TPB or
MOX-PM or MOX-PT respectively. On the other hand,
the determination of MOX in its formulations show an
average recovery of 98.0 or 98.5 or 98.5% with relative
standard deviation of 1.7 or 1.6 or 1.7% for sensor 1 or
2 or 3, respectively, results are shown in Table 5.
Results obtained for the analysis of MOX in its formula-
tion by direct measurements using the proposed sensors













Figure 4 Typical potentiometric titration curves of 5.0 ml of 1 × 10−2 M
moxifloxacin membrane sensors.in Table 5. The data obtained in Table 5 proves that the
potentiometeric method shows a high degree of precision
and accuracy compared with US pharmacopoeia method.
Application of MOX-PVC sensors as indictor electrodes
The developed electrodes in conjunction with an Ag/AgCl
reference electrode have been examined as an end point
indicator electrode for potentiometric titrations of the
drug. Titration MOX with sodium tetraphenylborate
using MOX-TPB or MOX-PM or MOX-PT sensors has
been performed (Figure 4). From the results it is clear
that MOX reacts with NaTPB in the molar ratio of 1:1.
The titration curves were symmetrical with a very well
defined potential jump of about 250 mV for MOX-TPB,
MOX-PM and MOX-PT respectively, indicating the high
sensitivity of the electrodes.
Conclusion
Three different ion-pair complexes of MOX have
been performed as sensors for MOX, the MOX mem-
brane sensor displayed good analytical performance.
The sensors display a fast, stable and near-Nernstian
response over a relative wide moxifloxacin concentra-
tion range (1 × 10−2 - 4.0 × 10−6, 1 × 10−2 - 5.0 × 10−6,




MOX with 1 × 10−2 M sodium tetraphenylborate using
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http://journal.chemistrycentral.com/content/8/1/59respectively over a pH range of 6.0 - 9.0. The direct de-
termination of moxifloxacin show an average recovery of
98.5, 99.1 and 98.6% and a mean relative standard devi-
ation of 1.8, 1.6 and 1.8% at 400 μg/ml for sensors 1, 2
and 3 respectively. The results obtained are within the
acceptance range of less than 3.0% (precision) and more
than 98.3% for the accuracy. The sensors have been
used as indicator electrodes for potentiometric titration
of moxifloxacin.
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